ESR1 and COVID-19: On the one hand, post-COVID-19 patients revealed numerous altered parameters of endothelial dysfunction, and subclinical inflammation expressed by elevated levels of CRP, ESR, and IL-6 as well as by a higher total number of pathologically altered inflammatory conditions (17, 25, 26).